At a glance
ClinicalIndex Comparison RecordN/ACompleted· 453 enrolled
Drug / intervention
ezetimibe +1 moredrug
Likely dose
ezetimibe 10 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Observational Study Evaluating the LDL-C Lowering Effects of Ezetimibe With a Statin as Prescribed in Daily Routine Practice in an Indonesian Population
In Brief
An observational study evaluating ezetimibe and statin for Hypercholesterolemia. Completed, enrolled 453 participants.
Detailed Summary
The purpose of this study is to evaluate the safety and tolerability of the low-density lipoprotein-cholesterol (LDL-C) lowering in an Indonesian population treated with ezetimibe co-administered with a statin in routine daily practice. In addition, the study will investigate whether and to what extent the target levels set by the participating doctors are achieved by the co-administration therapy.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHypercholesterolemia
Countries--
Collaborators--
Timeline
N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJan 2006
Primary CompletionDec 2007
First PostedJun 2008
TodayJul 2026
First PostedJun 25, 2008
Enrollment StartJan 1, 2006
Primary CompletionDec 1, 2007
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 18.0 years ago
Interventions
ezetimibedrug
10 mg once daily
statindrug